Pallas Capital Advisors LLC Sera Prognostics, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.24 Billion
- Q1 2025
A detailed history of Pallas Capital Advisors LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 13,857 shares of SERA stock, worth $47,113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,857
Previous 13,851
0.04%
Holding current value
$47,113
Previous $120,000
59.17%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SERA
# of Institutions
75Shares Held
20.3MCall Options Held
28.9KPut Options Held
36.8K-
Baker Bros. Advisors LP New York, NY5.43MShares$18.5 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$10.3 Million0.43% of portfolio
-
Interwest Venture Management CO2.42MShares$8.22 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$5.61 Million2.79% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$4.79 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $101M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...